naltrexone and isradipine

naltrexone has been researched along with isradipine in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (50.00)18.2507
2000's5 (35.71)29.6817
2010's2 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Chavkin, C; Gibbs, SM; Simmons, ML; Terman, GW1
Cramer, CM; Hubbell, CL; Pabello, NG; Reid, LD1
Boedeker, KL; Gardell, LR; Hubbell, CL; Liakos, TM; Reid, LD1
Boedeker, KL; Cramer, CM; Gardell, LR; Harris, JR; Hubbell, CL; Reid, LD1
Cramer, CM; Hubbell, CL; Reid, LD1
Barringer, TM; Cavallaro, CA; Hubbell, CL; Mendez, JJ; Pabello, NG; Reid, LD1
Ahmed, MS; Cemerikic, B; Zamah, R1
Boedeker, KL; Douglass, AV; Hubbell, CL; Reid, LD; Reid, ML1
Kosten, TR; McCance-Katz, FE; Oliveto, A; Petrakis, I; Singha, A; Sofuoglu, M1

Reviews

1 review(s) available for naltrexone and isradipine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for naltrexone and isradipine

ArticleYear
Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans.
    Pharmacology, biochemistry, and behavior, 2003, Volume: 75, Issue:4

    Topics: Adult; Area Under Curve; Behavior, Addictive; Blood Pressure; Cocaine-Related Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Isradipine; Male; Naltrexone

2003

Other Studies

12 other study(ies) available for naltrexone and isradipine

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
L-type calcium channels mediate dynorphin neuropeptide release from dendrites but not axons of hippocampal granule cells.
    Neuron, 1995, Volume: 14, Issue:6

    Topics: Animals; Axons; Calcium Channel Blockers; Calcium Channels; Dendrites; Dynorphins; Guinea Pigs; Hippocampus; Isradipine; Long-Term Potentiation; Naltrexone; Nifedipine; omega-Conotoxin GVIA; Peptides; Receptors, Opioid, kappa

1995
Isradipine in combination with naltrexone as a medicine for treating cocaine abuse.
    Life sciences, 1997, Volume: 60, Issue:8

    Topics: Animals; Calcium Channel Blockers; Cocaine; Drug Therapy, Combination; Electric Stimulation; Isradipine; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Substance-Related Disorders

1997
Isradipine and naltrexone in combination with isradipine interact with a period of abstinence to reduce rats' intakes of an alcoholic beverage.
    Alcoholism, clinical and experimental research, 1997, Volume: 21, Issue:9

    Topics: Alcohol Drinking; Alcoholic Beverages; Animals; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Ethanol; Isradipine; Male; Naltrexone; Rats; Rats, Sprague-Dawley; Self Administration

1997
Isradipine combined with naltrexone persistently reduces the reward-relevant effects of cocaine and alcohol.
    Pharmacology, biochemistry, and behavior, 1998, Volume: 60, Issue:2

    Topics: Animals; Body Weight; Calcium Channel Blockers; Central Nervous System Depressants; Cocaine; Conditioning, Operant; Drinking; Drug Interactions; Ethanol; Isradipine; Male; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Reward

1998
A combination of isradipine and naltrexone blocks cocaine's enhancement of a cocaine place preference.
    Pharmacology, biochemistry, and behavior, 1998, Volume: 60, Issue:4

    Topics: Animals; Calcium Channel Blockers; Cocaine; Conditioning, Operant; Dose-Response Relationship, Drug; Isradipine; Male; Mental Recall; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Substance-Related Disorders

1998
Responding for rewarding brain stimulation: cocaine and isradipine plus naltrexone.
    Pharmacology, biochemistry, and behavior, 1998, Volume: 61, Issue:2

    Topics: Analysis of Variance; Animals; Brain; Calcium Channel Blockers; Cocaine-Related Disorders; Drug Therapy, Combination; Electric Stimulation; Fluoxetine; Isradipine; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Reward; Valproic Acid

1998
Identification of L-type calcium channels associated with kappa opioid receptors in human placenta.
    Journal of molecular neuroscience : MN, 1998, Volume: 10, Issue:3

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Benzeneacetamides; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Cell Membrane; Chorionic Gonadotropin; Chorionic Villi; Culture Techniques; Egtazic Acid; Female; Humans; Isradipine; Naltrexone; Nifedipine; Placenta; Pyrrolidines; Receptors, Opioid, kappa; Trophoblasts

1998
Research with rats germane to medication for alcoholism: consequences of noncompliance.
    Alcohol (Fayetteville, N.Y.), 2001, Volume: 24, Issue:3

    Topics: Alcohol Drinking; Alcoholism; Animals; Calcium Channel Blockers; Drinking; Drug Therapy, Combination; Isradipine; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Temperance

2001